A New Treatment Nearly Halves The Risk of Disease Progression or Death from a less Common Form of Breast Cancer that has been major drug Advances in Over a Decade, Results from the Study, presented at the annual meeting of the American Society for Clinical Oncology and Could Soon Establish A New FIRST-LINE THERAPY FOR PEOPLE With HER2-POSITIVE METASTATIC BREAST CANCER. Meanwhile, Researchers are combining rna and ai to develop tailor-made vaccines to fight cancer. For a Depert Understanding of Anti-Cancer Drug Development, France 24’s François Picard Welcome Dr. Moez Benali, Oncology Global Senior Medical Director of Clinical Development and Global Head of Medical Affairs at Labcorp.
Source link
RNA COVID VACINE WAS Initially ‘Developed for ONCOLOGY USE AND WAS ALREADY in Phase 2’
